Cancer-associated Thrombosis
📧 Sign up to get email alerts when something new happens for Cancer-associated Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis [Phase 3]
A Phase 3 clinical trial evaluating REGN7508 for the prevention of cancer-associated thrombosis in adult participants is currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis [Phase 4]
Phase 4 clinical trial update evaluating anticoagulation strategies in patients with cancer-associated thrombosis and thrombocytopenia, curr…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis
This clinical trial is developing a risk-stratification score to predict recurrent venous thromboembolism and treatment-related bleeding in …
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: API-CAT STUDY for APIxaban Cancer Associated Thrombosis [Phase 3]
The Phase 3 API-CAT trial evaluating APIxaban for cancer-associated thrombosis has completed.
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT
Clinical trial evaluating thromboembolic and hemorrhagic complications of anticoagulant treatment in patients with cancer-associated thrombo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Gynecological Cancer Associated Thrombosis (GynCAT) Study
The Gynecological Cancer Associated Thrombosis (GynCAT) study is currently recruiting to investigate cancer-associated thrombosis and venous…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism [Phase 2]
A Phase 2 randomized open-label study comparing subcutaneous dalteparin to direct oral anticoagulants for cancer-associated venous thromboem…
-
CLINICAL_TRIALS research · 2014-12-04Clinical Trial Update: EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial [NA]
This clinical trial update notes that the EXPECT pilot trial, evaluating exercise training to prevent cancer-associated thrombosis, has comp…